Effcet of Temporomandibular Joint Disorder Relaxation and Myofacial Relaxation Techniques on Tension Headache
NCT ID: NCT05058573
Last Updated: 2021-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
66 participants
INTERVENTIONAL
2021-04-10
2021-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myofascial relaxation technique + Temporomandibular joint release techniques group (n=22)
medical treatment + temporomandibular joint relaxation (temporalis, masseter, and suboccipital muscles) + myofasial release/trigger points (trapezius, rhomboideus, and levator scapulae, sternocleidomastoideus muscles),
Control group (n=22)
Control group will be received only medical treatment
Temporomandibular joint release techniques group (n=22)
only temporomandibular joint relaxation will be performed in this group (temporalis, masseter, and suboccipital muscles).
Control group (n=22)
Control group will be received only medical treatment
Control group (n=22)
only medication treatment will be applied
Control group (n=22)
Control group will be received only medical treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control group (n=22)
Control group will be received only medical treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* individuals diagnosed with Temporomandibular joint dysfunction by dentist-maxillofacial surgeon
* To be able to read and understand Turkish
* Have not received any medical treatment in the last 1 year.
Exclusion Criteria
* who with any neurological problems
* who with any mental prolems
* who with any konjenital disorders
* who have undergone any cervikal or cranial surgery
* who have any facial trauma or facial paralyses
* who have advanced cervikal disc herniation
* who have ankylosing spondlitis, rhematoid arthritis, fibromyalgia
* who have any cominication problems
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alanya Alaaddin Keykubat University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayça Araci
Physical Therapist,principal investigator, pHd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanifegül Taşkıran, Prof. Dr
Role: STUDY_CHAIR
İstanbul Aydın University
Mustafa Zafer DEMİRTAŞ, MD
Role: STUDY_DIRECTOR
Alanya Alaaddin Keykubat University
Ertan KARAÇAY, MD
Role: STUDY_DIRECTOR
Alanya Alaaddin Keykubat University
Ahmet ÖZŞİMŞEK, PHD MD
Role: STUDY_DIRECTOR
Alanya Alaaddin Keykubat University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alanyaaku
Antalya, Alanya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10354421-2021/07-08
Identifier Type: -
Identifier Source: org_study_id